Jennifer Sue Pitrak Mcdonald

Array ( [id] => 9662535 [patent_doc_number] => 08809514 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference' [patent_app_type] => utility [patent_app_number] => 12/442278 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 37626 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12442278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693098 [patent_doc_number] => 20080085869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'DUPLEX OLIGONUCLEOTIDE COMPLEXES AND METHODS FOR GENE SILENCING BY RNA INTERFERENCE' [patent_app_type] => utility [patent_app_number] => 11/858829 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34775 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085869.pdf [firstpage_image] =>[orig_patent_app_number] => 11858829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682822 [patent_doc_number] => 20080249048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Methods and Compositions for the Treatment of Intestinal Conditions' [patent_app_type] => utility [patent_app_number] => 11/858579 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14437 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249048.pdf [firstpage_image] =>[orig_patent_app_number] => 11858579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228965 [patent_doc_number] => 20100183703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING A DOUBLE STRANDED RNA OLIGONUCLEOTIDE AND ITS USE AS AN ACTIVE PHARMACEUTICAL INGREDIENT IN THE TREATMENT OF ANDROGEN RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/442175 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5436 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183703.pdf [firstpage_image] =>[orig_patent_app_number] => 12442175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845499 [patent_doc_number] => 20080181907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'METHODS AND KITS FOR DIAGNOSING AND TREATING B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 11/847936 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20139 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181907.pdf [firstpage_image] =>[orig_patent_app_number] => 11847936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903946 [patent_doc_number] => 20080113359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'DNAZYMES AND SENSORS INCORPORATING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/846796 [patent_app_country] => US [patent_app_date] => 2007-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7006 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113359.pdf [firstpage_image] =>[orig_patent_app_number] => 11846796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734381 [patent_doc_number] => 20080051361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'RNAI-MEDIATED INHIBITION OF GREMLIN FOR TREATMENT OF IOP-RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 11/844869 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11069 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051361.pdf [firstpage_image] =>[orig_patent_app_number] => 11844869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784279 [patent_doc_number] => 08431119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 11/842983 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3604 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11842983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101652 [patent_doc_number] => 20110165144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'METHODS FOR TREATING RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 12/377538 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10875 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165144.pdf [firstpage_image] =>[orig_patent_app_number] => 12377538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939382 [patent_doc_number] => 20080076701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'DICER SUBSTRATE RNA PEPTIDE CONJUGATES AND METHODS FOR RNA THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/837432 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 36146 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076701.pdf [firstpage_image] =>[orig_patent_app_number] => 11837432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921512 [patent_doc_number] => 20080069827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'miRNA of HSV-LAT and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/889220 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11687 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069827.pdf [firstpage_image] =>[orig_patent_app_number] => 11889220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527827 [patent_doc_number] => 08304397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Identification of a micro-RNA that activates expression of β-myosin heavy chain' [patent_app_type] => utility [patent_app_number] => 11/831427 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 37 [patent_no_of_words] => 31272 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11831427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786470 [patent_doc_number] => 20080139799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'siRNA Targeting synuclein, alpha (SNCA-1)' [patent_app_type] => utility [patent_app_number] => 11/880965 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34614 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139799.pdf [firstpage_image] =>[orig_patent_app_number] => 11880965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711869 [patent_doc_number] => 20080300395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'siRNA targeting vascular endothelial growth factor receptor 1 (VEGFR1)' [patent_app_type] => utility [patent_app_number] => 11/880855 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34911 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300395.pdf [firstpage_image] =>[orig_patent_app_number] => 11880855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 152252 [patent_doc_number] => 07678896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)' [patent_app_type] => utility [patent_app_number] => 11/818938 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 35012 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678896.pdf [firstpage_image] =>[orig_patent_app_number] => 11818938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693226 [patent_doc_number] => 20080085997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'siRNA targeting phosphoinositide-3-kinase, class 2, beta polypeptide (PIK3C2B)' [patent_app_type] => utility [patent_app_number] => 11/811209 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34992 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085997.pdf [firstpage_image] =>[orig_patent_app_number] => 11811209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5248078 [patent_doc_number] => 20070244312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'siRNA targeting phosphoinositide-3-kinase, class 2, alpha polypeptide (PIK3C2A)' [patent_app_type] => utility [patent_app_number] => 11/811424 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34790 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244312.pdf [firstpage_image] =>[orig_patent_app_number] => 11811424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231344 [patent_doc_number] => 20070293452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial' [patent_app_type] => utility [patent_app_number] => 11/808212 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 46188 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293452.pdf [firstpage_image] =>[orig_patent_app_number] => 11808212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016838 [patent_doc_number] => 20070260047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'siRNA targeting EPH receptor A4 (EPHA4)' [patent_app_type] => utility [patent_app_number] => 11/810382 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34554 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20070260047.pdf [firstpage_image] =>[orig_patent_app_number] => 11810382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225782 [patent_doc_number] => 20070255049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'siRNA targeting EPH receptor A3 (EPHA3)' [patent_app_type] => utility [patent_app_number] => 11/810383 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34962 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20070255049.pdf [firstpage_image] =>[orig_patent_app_number] => 11810383 [rel_patent_id] =>[rel_patent_doc_number] =>)